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CLINICAL ANALYSIS OF THE DYNAMICS OF CHANGES SCAR 
TISSUE CHANGES AT DIFFERENT STAGES OF PREVENTING 
PATHOLOGICAL SCARS OF HEAD AND NECK
The work is a fragment of R & D Department of Operative Dentistry 
and Maxillofacial Surgery with plastic and reconstructive surgery of the 
head and neck -  «Optimization of conservative and surgical treatment of 
patients with defects and deformations of the tissues of the maxillofacial 
region, № State registration №0110U004629.
Breaking the skin leads to scarring. Regulation of the process depends 
on many factors. Factors due to the depth and area of damage, for a period 
of wound healing process, the cause of the traumatic agent, decreased 
immunity, endocrinopathy, anemia, impaired associative microflora, 
reducing microcirculation and local hemodynamics [1-3].
Many authors have focused on the notion of «a tendency to form», but 
did not cover the fundamental determination of this term [4].
Abnormal scars were divided into three groups: a real keloid, false 
keloid and hypertrophic scar. This keloid occurs for no apparent reason, 
which gives reason to think about the predisposition to develop it for 
individuals. Unreal keloid can occur at any pre-damaged area of the body 
and on the site of the former scar with the transition to healthy skin [5, 6].
We have justified the term’ tendency to pathological scarring with 
clinical, morphological and genetic point of view [7-12].
The aim of the work was to develop an optimal method of preventing 
postoperative pathological scarring in patients who are prone to their formation.
The object of the study: 18 patients who were treated after the planned 
interventions are prone to abnormal scarring.
To prevent the formation of pathological scars carried in scar injection
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drug «Lipin» № 5, rubbing cream «Dermofibraze» 3 times a day. After 
3 months of maturation of the scar electrophoresis preparation « Lipin» 
№ 10 per day with a traditional phonophoresis of hydrocortisone in 
a day, massaging cream «Dermofibraze». After 6 months, a refresher 
prevention by electrophoresis solution «Lipin» in the above procedure 
while Ultraphonophoresis cream «Dermofibraze» № 15 per day. Repeated 
preventive measures were carried out with 9 months.
For the clinical assessment of the dynamics of scarring at the stages of 
prevention, namely 3, 6, 9, 12 months, we used table that characterized the 
formation of scars on five criteria: a sign of P1 -  the type of scar, a sign of 
P2 -  the consistency of the scar, a sign of P3 -  the color of the scar, a sign 
of P4 -  the sensitivity of the scar, a sign of the P5 -  the area of the scar.
To determine the elastin gene polymorphism in exon 20 g28197 A> 
G we carried out the selection of genomic DNA from venous blood of the 
subjects with a set of «DNA -express- blood.»
We conducted a morphological study was aimed at identifying the 
histological features of the structure of pathological scarring and changes 
in the process of prevention.
Results and Discussion. In the study of the dynamics of clinical changes 
found that the application of prevention in patients with viyalenim elastin gene 
polymorphism, the most positive changes in observed parameter P2 -  the 
consistency of the scar, especially after three months of preventive measures. 
At the 12 month a sign of normal consistency of the scar was observed in 9 
(50%) patients. The slowest rate unchanged P4 the sensitivity of the scar from 
3 to 9 month prophylaxis with preservation of this parameter to 12 months of 
prophylaxis. 12 month scar strength characteristics defined in 8 (45%) patients. 
Changing the parameter P1 -  type ofscar indicates deterioration ofthis indicator 
between 6 and 9 months of prophylaxis, but a significant decrease after 3 stages. 
After 12 months in 6 (34%) patients had a homogeneous hypertrophic scar and
2 (11%) patients with hypertrophic scar nodules. Signs of normal atrophic scar 
formation were observed in 9 (50%) patients. Indicator P5 -  the area of the 
scar, which significantly decreased from 3 to 6 month prophylaxis after which 
the parameter remained unchanged. At month 12 was a sign of the first stage 
16 (89%) patients. In 2 (11%) ofthe patients was determined the mean area.
Significantly decreased P3 parameter -  the color of the scar. The most 
significant trend was observed from 3 to 6 month prophylaxis followed by 
a slow decrease after his 2 and 3 stages of preventive measures. At month 
12 healthy skin features defined in 15 (84%) patients.
Analysis of allele frequencies showed that the G allele was significantly 
more common in patients who are prone to abnormal scarring. We found a 
significant relationship between the presence of the polymorphic allele G 
and an increased risk of abnormal scarring.
Immunohistochemical study of histological sections of scars from 
patients diagnosed with elastin gene polymorphism markers using 
established that epithelial cells are found, which on its surface to marker
3 expressing CD and CD 68 respectively, and have intraepitelialnimi
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T - lymphocytes and macrophages and makrkera Key 67 confirmed a 
significant proliferative activity of fibroblasts.
Conclusion. Thus, the analysis of the dynamics of changes in clinical 
parameters characterizing the formation scar modified tissues showed that 
all of them reach the descent after our method of prevention. Patients are 
prone to abnormal scarring a statistically significant indicator of normal 
atrophic scarring in 11 (53%) patients.
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